Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4750 (-1.64%) ($7.4750 - $7.4750) on Mon. May. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 24 | Latest Price | $7.4750(-1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(26%) XLRE(24%) BND(22%) BWX(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.495% in a week (0% probabilities). VIXM(-18%) VXX(-17%) UUP(-14%) TLT(-11%) VCIT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.92 | 5 Day Moving Average | $7.52(-0.6%) | 10 Day Moving Average | $7.51(-0.47%) | 20 Day Moving Average | $7.92(-5.62%) | To recent high | -30.3% | To recent low | 1.2% | Market Cap | $1.319b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |